Kapiva is the D2C Ayurveda brand from India that has made a bold move recently. The company secured $60 million in funding in a Series D round. This money will support research, manufacturing, marketing, and expanding Kapiva’s reach beyond India. Along with current backers including Vertex Ventures Southeast Asia and 3one4 Capital, 360 ONE Asset and Vertex Growth are leading the round.

Kapiva was founded in 2016 by Ameve Sharma, Shrey Badhani, and Anuj Sharma. Combining the direct-to-consumer (D2C) business strategy with centuries-old Ayurveda was the strategy at hand. 

This latest round is significant not just for the amount but for how it is structured. $28 million was a primary capital infusion to fund growth and expansion. The remaining $32 million was a secondary transaction giving exits to some early investors. They plan to strengthen their health-tech platform, possibly utilizing data, personalization, and technology to serve wellness customers better.

First, it shows that investor confidence in Ayurveda meets modern consumer health. When traditional wellness meets design, branding, science, and tech, there is huge potential. Second, Kapiva’s plan to go global means Indian wellness brands are preparing to compete in international health and nutrition markets, not just domestic ones. Third, this round is large for the D2C wellness / ayurvedic space. It raises the bar for what consumers, investors, and competitors will expect next. Fourth, it provides Kapiva with the resources to build supply chains, ensure quality control, and maintain regulatory compliance across geographies. These are significant challenges in health products.So, more than money, this is a vote of confidence in Kapiva’s vision and capability.

In the U.S., Kapiva already has a wholly-owned subsidiary. In new markets, Kapiva will likely focus on wellness-conscious, diaspora populations, premium channels, and e-commerce first. It may also team with local players for distribution and compliance. They plan to invest in marketing, local partnerships, and building brand awareness as an Indian wellness brand with authenticity and science behind it.

From interviews, Kapiva leadership says the funding will allow them to “expand R&D, manufacturing, and marketing investments.” They also emphasize that the raise is both for expansion and to let early investors exit in a healthy way.

“In Ayurveda, only a small part is about treating illness. The larger part, almost ninety percent, is about staying healthy. That is where we see the real power of this tradition. It helps people prevent problems before they even begin,” says Ameve Sharma. “Millennials today face lifestyle issues every single day. It is not enough to treat the surface symptoms. We must look at the root cause and its depth. That is how we create real and lasting solutions,” he added

Kapiva’s fundraiser will create ripple effects. It will push other wellness startups to scale, seek global ambitions, and build robust platforms. It will also attract more investor interest into Ayurveda, holistic health, and consumer healthcare. It may also challenge incumbents and FMCG brands to pay attention. Domestic wellness and global competition may accelerate innovation in supply chain, product science, brand building. Kapiva’s $60 million raise proves that Indian wellness brands can dream global. It shows that Ayurveda in a modern avatar, backed by science, branding, and scale, has global potential.

Also read | The Viral Video of an Indian Entrepreneur Choosing Home Over Abroad

Stay tuned with BharatLinkr for many more inspiring stories.